Skip to main content

Advertisement

Log in

Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients

  • Laryngology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Between June 1983 and December 2002, 32 patients were treated for primary localized laryngo-tracheobronchial amyloidosis (LTBA) at our institution. For enrollment in this retrospective study, at least one positive biopsy with Congo red stain and a diagnostic test battery excluding systemic or secondary amyloidosis were mandatory. The most common presenting symptom was dyspnea, which was observed in 75% of cases. Endoscopic appearance was described as submucosal plaques and nodules with a cobblestone appearance in 44% of patients, tumor-like in 28% and circumferential wall thickening in 28% of cases. Tracheobronchopatia osteochondroplastica was associated with LTBA in 22% of patients, both at the first treatment (four cases) or during follow-up examinations (three). Synchronous or metachronous disease in the larynx and tracheobronchial tree was observed in 47% of cases, while only one patient showed lung involvement with extensive amyloidosis of the trachea and bronchi. All but two patients were endoscopically treated. One of these was affected by a tracheal amyloidoma cured by endoscopic debulking and further tracheal resection-anastomosis. The other patient presented massive laryngo-pharyngeal involvement and was therefore treated by total laryngectomy. A total of 58 endoscopic procedures (range: 1–7; mean: two per patient) were carried out, 11 with CO2 laser (for supraglottic, glottic and selected subglottic lesions) and 47 with Nd:YAG laser (for the most part of subglottic lesions and amyloid deposits located in trachea and bronchi). Four patients required a tracheotomy and three necessitated a T-tube stent during management, which was subsequently removed in all cases. One patient was lost to follow-up, nine were endoscopically controlled elsewhere (Group A) and 22 were followed at our institution (Group B). In Group A, the patient with tracheal amyloidoma is asymptomatic and free of additional LTBA localizations 8 years after surgery. The remaining eight are asymptomatic, but with persistent endoscopic signs of amyloidosis. In Group B, five patients died: one from heart failure and another one from pneumonia 3 and 4 days after surgery, respectively. In one case death was from unrelated causes, and in the two remaining patients it was from respiratory failure due to uncontrolled bilateral bronchial amyloidosis in the subsequent 5 to 6 years. One patient is completely cured 5 years after surgery, and 16 are asymptomatic with persistence of LTBA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  1. Alroy GG, Lichtig C, Kaftori JK (1972) Tracheobronchopathia osteoplastica: end stage of primary lung amyloidosis? Chest 61: 465–468

    CAS  PubMed  Google Scholar 

  2. Berg AM, Troxler RF, Grillone G, Kasznica J, Kane K, Cohen AS, Skinner M (1993) Localised amyloidosis of the larynx: evidence for light chain composition. Ann Otol Rhinol Laryngol 102: 884–889

    CAS  PubMed  Google Scholar 

  3. Capizzi SA, Betancourt E, Prakash UBS (2000) Tracheobronchial amyloidosis. Mayo Clin Proc 75: 1148–1152

    CAS  PubMed  Google Scholar 

  4. Cavaliere S, Beamis J (1991) Endoscopic views — laser. In: Cavaliere S, Beamis J (eds) Atlas of therapeutic bronchoscopy. Laser — stents. Apollonio and Company, Brescia, p 55

  5. Chen KTK (1989) Amyloidosis presenting in the respiratory tract. Pathol Annu 24: 253–273

    PubMed  Google Scholar 

  6. Cordier JF, Loire R, Brune J (1986) Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest 90: 827–831

    CAS  PubMed  Google Scholar 

  7. Diaz-Jimenez JP, Rodriguez A, Ballarin JIM, Castro MJ, Argemi TM, Manresa F (1999) Diffuse tracheobronchial amyloidosis. J Bronchol 6: 13–17

    Google Scholar 

  8. Flemming AFS, Fairfax AJ, Arnold AG, Lane DJ (1980) Treatment of endobronchial amyloidosis by intermittent bronchoscopic resection. Br J Dis Chest 74: 183–188

    CAS  PubMed  Google Scholar 

  9. Hui AN, Koss MN, Hochholzer L, Wehunt WD (1986) Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases. Arch Pathol Lab Med 110: 212–218

    CAS  PubMed  Google Scholar 

  10. Jones AW, Chatterji AN (1977) Primary tracheobronchial amyloidosis with tracheobronchopathia osteoplastica. Br J Dis Chest 71: 268–272

    CAS  PubMed  Google Scholar 

  11. Kennedy TL, Patel NM (2000) Surgical management of localized amyloidosis. Laryngoscope 110: 918–923

    CAS  PubMed  Google Scholar 

  12. Lewis JE, Olsen KD, Kurtin PJ, Kyle R (1992) Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg 106: 372–377

    CAS  PubMed  Google Scholar 

  13. Mares DC, Broderick LS, Cummings OW, Benson MD, Mathur PN (1998) Tracheobronchial amyloidosis: a review of clinical and radiographic characteristics, bronchoscopic diagnosis, and management. J Bronchol 5: 147–155

    Google Scholar 

  14. Merlini G (1995) Treatment of primary amyloidosis. Semin Hematol 32: 60–79

    CAS  PubMed  Google Scholar 

  15. Nienhuis DM, Prakash UBS, Edell ES (1990) Tracheobronchopathia osteochondroplastica. Ann Otol Rhinol Laryngol 99: 689–694

    CAS  PubMed  Google Scholar 

  16. O'Regan A, Fenlon HM, Beamis JF, Steele MP, Skinner M, Berk JL (2000) Tracheobronchial amyloidosis. The Boston University experience from 1984 to 1999. Medicine 79: 69–79

    Article  CAS  PubMed  Google Scholar 

  17. Sakula A (1968) Tracheobronchopathia osteoplastica: its relationship to primary tracheobronchial amyloidosis. Thorax 23: 105–110

    CAS  PubMed  Google Scholar 

  18. Schulz C, Hauck RW, Nathrath WB, Prauer HW, Linke RP, Emslander HP (1995) Combined amyloidosis of the upper and lower respiratory tract. Respiration 62: 163–166

    CAS  PubMed  Google Scholar 

  19. Shaheen NA, Salman SD, Nassar VH (1975) Fatal bronchopulmonary hemorrhage due to unrecognized amyloidosis. Arch Otolaryngol 101: 259–261

    CAS  PubMed  Google Scholar 

  20. Thompson PJ, Jewkes J, Corrin B, Citron KM (1983) Primary bronchopulmonary amyloid tumour with massive hilar lymphadenopathy. Thorax 38: 153–154

    CAS  PubMed  Google Scholar 

  21. Toyoda M, Ebihara Y, Kato H, Kita S (1993) Tracheobronchial AL amyloidosis: histological, immunohistochemical, ultrastructural and immunoelectron microscopic observations. Hum Pathol 24: 970–976

    CAS  PubMed  Google Scholar 

  22. Utz JP, Swensen SJ, Gertz MA (1996) Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993. Ann Intern Med 124: 407–413

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giorgio Peretti.

Additional information

This study was presented in part at the Fourth European Laryngological Society Congress in Brussels, Belgium, 5–7 September 2002.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piazza, C., Cavaliere, S., Foccoli, P. et al. Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients. Eur Arch Otorhinolaryngol 260, 349–354 (2003). https://doi.org/10.1007/s00405-003-0592-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-003-0592-0

Keywords

Navigation